This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,601 Years Active: 2013
Title: The Innovative Contributions of Sabra Begum
Introduction
Sabra Begum is a notable inventor based in Karachi, Pakistan. She has made significant strides in the field of pharmaceuticals, particularly in the development of antitubercular drugs. Her work is characterized by a commitment to addressing critical health challenges through innovative solutions.
Latest Patents
Sabra Begum holds a patent for an antitubercular alkaloid. This patent, titled "A derivative of β-carboline alkaloid harmine, 10,12-diheptanoyl-11-hydroxy-3-methyl-β-carboline," is prepared by a Friedel-Crafts acylation of harmine. It is reported as a novel potent antitubercular drug, showcasing her ability to contribute to medical advancements.
Career Highlights
Throughout her career, Sabra has demonstrated a strong dedication to research and innovation. Her work has not only contributed to the scientific community but has also aimed to improve public health outcomes. With a focus on developing effective treatments, she has established herself as a key figure in her field.
Collaborations
Sabra has collaborated with notable colleagues, including Bina Shaheen Siddiqui and Syed Nawazish Ali. These partnerships have enhanced her research efforts and expanded the impact of her work in the pharmaceutical industry.
Conclusion
Sabra Begum's contributions to the field of antitubercular drug development highlight her innovative spirit and dedication to improving health outcomes. Her patent and collaborative efforts reflect her commitment to making a difference in the world of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile